Page 6 - உலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

South Africa joins global clinical trial of new antibio

The Global Antibiotic Research and Development Partnership (GARDP) has launched a stage-three trial of zoliflodacin, a potential new antibiotic to treat gonorrhoea, in South Africa as well as the United States, the Netherlands and Thailand. The World Health Organisation started the GARDP in 2016. It is a non-profit organisation focused on developing new treatments for infections which have become resistant to available treatments. It says its mission is to produce new medicines which are accessible and affordable to all who need them. Zoliflodacin is being trialled at three sites in South Africa – the Wits Reproductive Health and HIV Institute based at the Hillbrow Health Precinct in Johannesburg, and two South African Medical Research Council sites at Tongaat and Botha’s Hill in KwaZulu-Natal.

United statesSouth africaKwazulu natalEastern capeSouth africanBotha hillSeamus obrienEdward mukwayaSinead delany moretlweHillbrow health precinctAfrican health products regulatory authorityWits reproductive healthDevelopment partnershipWorld health organisationGlobal antibiotic researchAfrican medical research council

GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting

GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting The following statement from Global Health Council, supported by the Global Health Technologies Coalition and the Infectious Diseases Society of America was delivered at the 148th session of the WHO Executive Board on Agenda Item 9: Antimicrobial resistance. The Global Health Council, Global Health Technologies Coalition, and Infectious Diseases Society of America thank the chair and distinguished delegates for this opportunity to comment on the ongoing work against resistance to antimicrobials from a large span of bacterial, viral, parasitic, and fungal microorganisms. According to a recent Lancet study, bacterial infections unsuccessfully treated due to antimicrobial resistance (AMR) claim at least 700,000 lives per year worldwide and are projected to be associated with the deaths of 10 million people per year by 2050.

United statesGlobal antibiotic researchGlobal health councilWorld health organizationDevelopment partnershipInfectious diseases society of americaGlobal health technologies coalitionInfectious diseases societyAgenda itemGlobal antimicrobial resistanceUse surveillance systemஒன்றுபட்டது மாநிலங்களில்உலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சிஉலகளாவிய ஆரோக்கியம் சபைஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்வளர்ச்சி கூட்டு

GHC Statement on Antimicrobial Resistance at the 148th Session of WHO Executive Board Meeting

GHC Statement on Antimicrobial Resistance at the 148th Session of WHO Executive Board Meeting January 25, 2021 The following statement from Global Health Council, supported by the Global Health Technologies Coalition and the Infectious Diseases Society of America was submitted to the 148th session of the WHO Executive Board on Agenda Item 9: Antimicrobial resistance. The Global Health Council, Global Health Technologies Coalition, and Infectious Diseases Society of America thank the chair and distinguished delegates for this opportunity to comment on the ongoing work against resistance to antimicrobials from a large span of bacterial, viral, parasitic, and fungal microorganisms. According to a recent

United statesGlobal antibiotic researchGlobal health councilWorld health organizationDevelopment partnershipInfectious diseases society of americaGlobal health technologies coalitionInfectious diseases societyAgenda itemGlobal antimicrobial resistanceUse surveillance systemஒன்றுபட்டது மாநிலங்களில்உலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சிஉலகளாவிய ஆரோக்கியம் சபைஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்வளர்ச்சி கூட்டு

Global Antibiotic Research and Development Partnership (GARDP)

Global Antibiotic Research and Development Partnership (GARDP)
ghtcoalition.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghtcoalition.org Daily Mail and Mail on Sunday newspapers.

Global antibiotic researchDevelopment partnershipஉலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சிவளர்ச்சி கூட்டு

Clinical Trial Manager

Program/Project Management Job in South Africa about Health, requiring 5-9 years of experience, from GARDP; closing on 04 Feb 2021

Cape townWestern capeSouth africaKwazulu natalSouth africanSouthern african officeGlobal antibiotic research development partnershipSouthern africa officeMinistries of healthSouthern africa finance administrationWorld health organisationNeglected diseasesGlobal antibiotic researchDevelopment partnershipSouthern africanJohannesburg south africa